Literature DB >> 21117387

Cardiovascular risk and prevention in diabetes mellitus.

Aled W Roberts1.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 21117387      PMCID: PMC4952416          DOI: 10.7861/clinmedicine.10-5-495

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  25 in total

Review 1.  Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology.

Authors:  David P Faxon; Valentin Fuster; Peter Libby; Joshua A Beckman; William R Hiatt; Robert W Thompson; James N Topper; Brian H Annex; John H Rundback; Rosalind P Fabunmi; Rose Marie Robertson; Joseph Loscalzo
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

2.  Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.

Authors:  Peter Libby; David M Nathan; Kristin Abraham; John D Brunzell; Judith E Fradkin; Steven M Haffner; Willa Hsueh; Marian Rewers; B Tibor Roberts; Peter J Savage; Sonia Skarlatos; Momtaz Wassef; Cristina Rabadan-Diehl
Journal:  Circulation       Date:  2005-06-28       Impact factor: 29.690

Review 3.  Type 1 diabetes and coronary artery disease.

Authors:  Trevor J Orchard; Tina Costacou; Adam Kretowski; Richard W Nesto
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

4.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

5.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

6.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

7.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

8.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

9.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Authors:  Rory Collins; Jane Armitage; Sarah Parish; Peter Sleigh; Richard Peto
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

Review 10.  Rosiglitazone for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C Clar; S H Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
View more
  2 in total

1.  Microvascular vasodilator properties of the angiotensin II type 2 receptor in a mouse model of type 1 diabetes.

Authors:  Marc-Antoine Begorre; Abdallah Dib; Khalil Habchi; Anne-Laure Guihot; Jennifer Bourreau; Emilie Vessieres; Bertrand Blondeau; Laurent Loufrani; Marie Chabbert; Daniel Henrion; Céline Fassot
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

2.  Nephroprotective effect of Artemisia herba alba aqueous extract in alloxan-induced diabetic rats.

Authors:  Omar Sekiou; Mahieddine Boumendjel; Faiza Taibi; Lazhari Tichati; Amel Boumendjel; Mahfoud Messarah
Journal:  J Tradit Complement Med       Date:  2020-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.